James A. Klein, Jr
2007
In 2007, James A. Klein, Jr earned a total compensation of $550.6K as Chief Financial Officer at FENNEC PHARMACEUTICALS, a 86% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $20,000 |
|---|---|
| Option Awards | $304,180 |
| Salary | $225,000 |
| Other | $1,413 |
| Total | $550,593 |
Klein received $304.2K in option awards, accounting for 55% of the total pay in 2007.
Klein also received $20K in non-equity incentive plan, $225K in salary and $1.4K in other compensation.
Rankings
In 2007, James A. Klein, Jr's compensation ranked 5,761st out of 8,700 executives tracked by ExecPay. In other words, Klein earned more than 33.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,761 out of 8,700 | 34th |
Division Manufacturing | 2,164 out of 3,314 | 35th |
Major group Chemicals And Allied Products | 472 out of 746 | 37th |
Industry group Drugs | 321 out of 546 | 41st |
Industry Biological Products, Except Diagnostic Substances | 57 out of 118 | 52nd |
Source: SEC filing on March 28, 2008.
Klein's colleagues
We found one more compensation record of an executive who worked with James A. Klein, Jr at FENNEC PHARMACEUTICALS in 2007.
2007
William Peters
FENNEC PHARMACEUTICALS